Amer Zureikat: Clinical Trials

2 trials sponsored by Amer Zureikat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Amer Zureikat: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Hydroxychloroquine, Gemcitabine - Pancreatic Cancer
Phase 1 / Phase 2CompletedAmer Zureikat352010-10-012019-05-01
Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer
Avastin (bevacizumab), Gemzar (Gemcitabine), external beam radiotherapy - Pancreatic Cancer
Phase 2CompletedAmer Zureikat592006-12-012018-09-25

Conditions studied

Pancreatic Neoplasms (2)  ·  Neoplasms (1)

Interventions

Gemcitabine (2)  ·  Bevacizumab (1)  ·  Hydroxychloroquine (1)

Countries

United States (2)

Top investigators

Herbert J. Zeh, MD (1)  ·  Herbert Zeh, MD (1)

Results publications

PMID 29929491